Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artivion (AORT) Operating Leases (2019 - 2025)

Artivion's Operating Leases history spans 7 years, with the latest figure at $34.4 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 13.91% year-over-year to $34.4 million; the TTM value through Dec 2025 reached $34.4 million, down 13.91%, while the annual FY2025 figure was $34.4 million, 13.91% down from the prior year.
  • Operating Leases reached $34.4 million in Q4 2025 per AORT's latest filing, down from $38.4 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $47.4 million in Q2 2021 to a low of $34.4 million in Q4 2025.
  • Average Operating Leases over 5 years is $42.4 million, with a median of $43.3 million recorded in 2022.
  • Peak YoY movement for Operating Leases: soared 219.72% in 2021, then fell 13.91% in 2025.
  • A 5-year view of Operating Leases shows it stood at $44.9 million in 2021, then dropped by 0.68% to $44.6 million in 2022, then decreased by 1.32% to $44.0 million in 2023, then decreased by 9.07% to $40.0 million in 2024, then dropped by 13.91% to $34.4 million in 2025.
  • Per Business Quant, the three most recent readings for AORT's Operating Leases are $34.4 million (Q4 2025), $38.4 million (Q3 2025), and $39.4 million (Q2 2025).